<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">477069576</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180405111421.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170330e19960101xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/BF01586187</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/BF01586187</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[W. Beyer, A. Palache, R. Kerstens, N. Masurel]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">In order to determine whether there is a difference between genders in reported adverse reactions to inactivated influenza vaccine, a computerized database of serological studies was investigated. A standardized questionnaire was used to evaluate vaccine reactogenicity. A total of 1,800 vaccinees in 14 studies were analyzed separately for two age groups (&lt;60 and ≥60 years of age). Females reported significantly more local reactions than males. The pooled odds ratio for the outcome measure &quot;any local reaction” was 0.32 (95% confidence interval, 0.26-0.40, significant) and 0.54 (95% Cl, 0.41-0.70, significant) for young and elderly adults, respectively. Similar results were obtained for the outcome measure &quot;any systemic reaction.” Previous exposure to influenza or influenza vaccine had no influence on reactogenicity. There were no gender differences in seroresponses. In conclusion, gender should be regarded as a predictor of reported reactions to influenza vaccine in both young and elderly adults and should be addressed in future study designs.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer-Verlag, 1996</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Beyer</subfield>
   <subfield code="D">W.</subfield>
   <subfield code="u">WHO National Influenza Centre, Department of Virology, Erasmus University Rotterdam, PO Box 1738, 3000, DR Rotterdam, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Palache</subfield>
   <subfield code="D">A.</subfield>
   <subfield code="u">WHO National Influenza Centre, Department of Virology, Erasmus University Rotterdam, PO Box 1738, 3000, DR Rotterdam, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Kerstens</subfield>
   <subfield code="D">R.</subfield>
   <subfield code="u">Department of Statistics and Data Management, Solvay Duphar bv, PO Box 900, 1380, DA Weesp, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Masurel</subfield>
   <subfield code="D">N.</subfield>
   <subfield code="u">WHO National Influenza Centre, Department of Virology, Erasmus University Rotterdam, PO Box 1738, 3000, DR Rotterdam, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">European Journal of Clinical Microbiology and Infectious Diseases</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">15/1(1996-01-01), 65-70</subfield>
   <subfield code="x">0934-9723</subfield>
   <subfield code="q">15:1&lt;65</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">15</subfield>
   <subfield code="o">10096</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/BF01586187</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/BF01586187</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Beyer</subfield>
   <subfield code="D">W.</subfield>
   <subfield code="u">WHO National Influenza Centre, Department of Virology, Erasmus University Rotterdam, PO Box 1738, 3000, DR Rotterdam, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Palache</subfield>
   <subfield code="D">A.</subfield>
   <subfield code="u">WHO National Influenza Centre, Department of Virology, Erasmus University Rotterdam, PO Box 1738, 3000, DR Rotterdam, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Kerstens</subfield>
   <subfield code="D">R.</subfield>
   <subfield code="u">Department of Statistics and Data Management, Solvay Duphar bv, PO Box 900, 1380, DA Weesp, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Masurel</subfield>
   <subfield code="D">N.</subfield>
   <subfield code="u">WHO National Influenza Centre, Department of Virology, Erasmus University Rotterdam, PO Box 1738, 3000, DR Rotterdam, The Netherlands</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">European Journal of Clinical Microbiology and Infectious Diseases</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">15/1(1996-01-01), 65-70</subfield>
   <subfield code="x">0934-9723</subfield>
   <subfield code="q">15:1&lt;65</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">15</subfield>
   <subfield code="o">10096</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
